Doxazosin Mesylate Tablet
Product Images NDC 59762-1389

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin Mesylate (NDC 59762-1389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Structural Formula (Image 01)

FDA Label Image

Table 3. (Image 02)

The text provides a summary of effectiveness data from placebo-controlled trials evaluating the maximum flow rate and symptom scores of participants taking Placebo and CARDURA at different dosages in studies 1, 2, and 3. The trials involved titration or fixed dosages over several weeks, assessing parameters like AUA questionnaire scores and Modified Boyarsky Questionnaire results. The data indicates a significant improvement in maximum flow rate and symptom scores with CARDURA compared to Placebo in these studies involving hypertensives with BPH.*

FDA Label Image

Figure 1 – Study 1 (Image 03)

FDA Label Image

Doxazosin Tablets Bottle Labels 1 mg (Image 04)

This text provides important information about storing and administering doxazosin tablets. It specifies a recommended storage temperature range of 15°C to 30°C (59°F to 86°F) with excursions permitted up to 25°C (77°F). Each tablet contains 1 mg of doxazosin mesylate. The product is distributed by Greenstone LLC from Morgantown, USA. The packaging includes 100 tablets of doxazosin, and it is under the Greenstone brand. The NDC code for the product is 59762-1388-7 with a GTIN of 75103159. The text also recommends referring to the prescribing information for the correct dosage.*

FDA Label Image

Doxazosin Tablets Bottle Labels 2 mg (Image 05)

This is a prescription medication in tablet form containing doxazosin mesylate equivalent to 2 mg of doxazosin as a free base. It is manufactured in Germany and distributed by Greenstone LLC in the USA under the brand name GREENSTONE®. The medication should be stored at room temperature between 15°C to 30°C (59°F to 86°F). The recommended dosage should be followed as per the prescribing information. Each bottle contains 100 tablets and is labeled with the NDC 59762-1389-7.*

FDA Label Image

Doxazosin Tablets Bottle Labels 4 mg (Image 06)

Store the medication at a temperature between 15°C to 30°C (59°F to 86°F), with excursions permitted. The tablets contain doxazosin mesylate equivalent to 4 mg of doxazosin. Each pack contains 100 tablets. Manufactured in Germany by a company named Greenstone LLC. Ensure to check the prescribing information for the recommended dosage.*

FDA Label Image

Doxazosin Tablets Bottle Labels 8 mg (Image 07)

Store at 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). This package contains 100 tablets of doxazosin mesylate equivalent to 8 mg of doxazosin as a free base. The recommended dosage can be found in the prescribing information. This product is made in Germany and distributed by Greenstone LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.